Versigent (NYSE:VGNT) Raised to “Hold” at Wall Street Zen

Versigent (NYSE:VGNT) was upgraded by analysts at Wall Street Zen to a “hold” rating in a report released on Saturday.

Several other equities analysts have also commented on the company. Royal Bank Of Canada assumed coverage on Versigent in a report on Tuesday, March 31st. They set a “sector perform” rating and a $28.00 target price for the company. Fox Advisors raised Versigent to a “strong-buy” rating in a report on Tuesday, April 7th. UBS Group assumed coverage on Versigent in a report on Tuesday, April 14th. They set a “buy” rating and a $43.00 target price for the company. Wells Fargo & Company assumed coverage on Versigent in a report on Monday, April 6th. They set an “overweight” rating and a $35.00 target price for the company. Finally, TD Cowen assumed coverage on Versigent in a report on Tuesday, April 14th. They set a “buy” rating and a $47.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Versigent presently has a consensus rating of “Moderate Buy” and an average price target of $38.25.

Versigent Trading Down 0.0%

NYSE:VGNT opened at $34.69 on Friday. Versigent has a 52 week low of $26.34 and a 52 week high of $35.08.